[The results of antibacterial therapy combined with prodigiozan in children with tuberculosis].
The paper presents the findings of a clinico-roentgenologic and immunologic follow-up of 100 children aged 3-14 years. The efficacy of the antibacterial treatment of children with different forms of intrathoracic tuberculosis supplemented by prodigiosan as well as that of prodigiosan alone were analysed by means of clinical, X-ray, laboratory and immunologic methods. By increasing the body reactivity, prodigiosan can promote higher rates of resolution of pathologic changes in the lungs. The data of this study permit one to recommend prodigiosan as an effective non-specific impact method in the combined treatment of tuberculosis in children.